Clik here to view.
FDA publishes Draft Guidance on developing drugs for early stages of...
Tweet Normal and Alzheimer’s brains compared. Once again, approaches to improving clinical trials for candidate disease-modifying drugs for Alzheimer’s disease (AD) are in the news. On February 7,...
View ArticleClik here to view.
FDA proposes accelerated approval of early-stage Alzheimer’s drugs based on...
TweetPittsburgh compound B staining in AD. Source: National Institute on Aging/NIH. In our February 28, 2013 article on the Biopharmconsortium Blog, we discussed the FDA’s February 7, 2013 Draft...
View ArticleClik here to view.
Cancer immunotherapy: the star of the ASCO Annual Meeting two years in a row!
TweetPD-L1 On June 28, 2012 we published an article on this blog entitled “Cancer Immunotherapy: The Star Of The 2012 ASCO Annual Meeting”. Now comes the American Society of Clinical Oncology (ASCO)...
View ArticleClik here to view.
Chemokine receptors and the HIV-1 entry inhibitor maraviroc
TweetMaraviroc In April 2012, Informa’s Scrip Insights published our book-length report, “Advances in the Discovery of Protein-Protein Interaction Modulators.” We also published a brief introduction...
View ArticleClik here to view.
Immune checkpoint inhibitors work by reactivating tumor-infiltrating T cells...
TweetCancer Cell The 27 November issue of Nature contains a wealth of new studies on how immune checkpoint inhibitors target various types of cancer, and how researchers and physicians might be able...
View Article
